Effective control of psoriasis by etanercept in a patient with HCV-related diseases

European Journal of Dermatology

Volumn 18, Issue 4, 2008, Pages 459-460

  Piccolo, Domenico ^a   Di Cesare, Antonella ^a   Fargnoli, Maria Concetta ^a   Paoloni, Maurizio ^b   Vecchiotti, Sergio ^b   Peris, Ketty ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Hospital of Avezzano   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYCLOSPORIN A; ETANERCEPT; METHOXSALEN;

ABSENCE OF SIDE EFFECTS; ADULT; CASE REPORT; DISEASE CONTROL; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG EFFICACY; HEPATITIS C; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LETTER; LIVER BIOPSY; MALE; PROTEINURIA; PSORIASIS VULGARIS; PUVA; TREATMENT RESPONSE;

DERMATOLOGIC AGENTS; HEPATITIS C; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 47749138516     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0443     Document Type: Letter

References (8)

1. Boehncke WH, Brasie RA, Barker J, Chimenti S, Dauden E, de Rie M, et al. Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus. J Eur Acad Dermatol Venereol 2006; 20: 988-98
2. Nelson DR, Lim HL, Marousis CG, Fang JW, Davis GL, Shen L, et al. Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig Dis Sci 1997; 42: 2487-94
3. Nasir A, Arora HS, Kaiser HE. Apoptosis and pathogenesis of viral hepatitis C - an update. In Vivo 2000; 14: 297-300
4. Zein NN, Etanercept Study Group. Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study. J Hepatol 2005; 42: 315-22
5. Vauloup C, Krzysiek R, Greangeot-Keros L, Wendling D, Goupille P, Brault R, Brousse C, Mariette X, Emilie D. Effects of tumor necrosis factor antagonist treatment on hepatitis C-related immunological abnormalities. Eur Cytokine Netw 2006; 17:290-3.
6. Magliocco MA, Gottlieb AB. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: Report of 3 cases. J Am Acad Dermatol 2004; 51: 580-4.
7. De Simone C, Paradisi A, Capizzi R, Carbone A, Siciliano M, Amerio PL. Etanercept therapy in two patients with psoriasis and concomitant hepatitis C. J Am Acad Dermatol 2006; 54: 1102-3.
8. Daghestani L, Pomeroy C. Renal manifestations of hepatitis C infection. Am J Med 1999; 106: 347-54.